ADAPT-HEM
Beijing Biotech
Beijing Biotech
ModernaTX, Inc.
Nanjing IASO Biotechnology Co., Ltd.
Regeneron Pharmaceuticals
Sumitomo Pharma America, Inc.
Celgene
Janssen Research & Development, LLC
Celgene
GlaxoSmithKline
Karyopharm Therapeutics Inc
Genmab
Dana-Farber Cancer Institute
Incyte Corporation
Regeneron Pharmaceuticals
Biotroy Therapeutics
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Zhejiang ACEA Pharmaceutical Co. Ltd.
Hoffmann-La Roche
Shanghai EpimAb Biotherapeutics Co., Ltd.
Chengdu Zenitar Biomedical Technology Co., Ltd
Multiple Myeloma Research Consortium
Celgene
University of Pittsburgh
Altor BioScience
Stemline Therapeutics, Inc.
Beijing Mabworks Biotech Co., Ltd.
University of Virginia
LaNova Medicines Limited
Oncotherapeutics
Fondazione EMN Italy Onlus
Takeda
Alliance Foundation Trials, LLC.
Karyopharm Therapeutics Inc
H. Lee Moffitt Cancer Center and Research Institute
University of Michigan Rogel Cancer Center
Gilead Sciences
University of Athens
Sun Yat-sen University
Novartis
Dana-Farber Cancer Institute
Icahn School of Medicine at Mount Sinai
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
Biotest Pharmaceuticals Corporation
NYU Langone Health
University Health Network, Toronto
Oncotherapeutics
AEterna Zentaris
Masonic Cancer Center, University of Minnesota